1. Introduction
===============

The translation of most eukaryotic mRNAs is initiated in a 5′-cap-dependent mechanism and in principle, this restricts protein synthesis to the first coding sequence on the mRNA. However, many RNA viruses have polycistronic genomes and thus, display a variety of strategies to allow downstream open reading frames (ORFs) to be accessed. Some viruses produce subgenomic-length RNAs in which the relevant downstream ORF is effectively moved to the 5′-end of the RNA from where it can be efficiently translated. Where the replication cycle involves a nuclear step, RNAs can be spliced by the cellular machinery and many cytoplasmically replicating viruses have evolved mechanisms to produce subgenomic mRNAs during transcription. In other viruses, the 5′-end problem is obviated simply by encoding all of the required information in a single ORF and subsequent processing of the encoded polyprotein proteolytically. Viruses have also evolved a number of unconventional translation strategies to express distal ORFs. These include leaky scanning, where the AUG of the 5′-most ORF is inefficiently recognised and ribosomes scan on to initiate at a downstream ORF; ribosomal re-initiation, where a post-termination complex remains associated with the mRNA and re-initiates translation at a downstream ORF and translational fusion, where two (or more) ORFs separated by a stop codon or in an overlapping configuration are translated as a single protein following termination codon suppression or programmed ribosomal frameshifting, respectively (reviewed in [@bib53], [@bib106]).

Ribosomal frameshifting, the focus of this review, is a process where specific signals in the mRNA instruct the ribosome to change reading frame from the 0 to the −1 frame (movement 5′-wards) at a certain efficiency and to continue translation in the new frame. Frameshift signals are thus found within overlapping coding sequences. Several viruses employ frameshifting during replication, including retroviruses (excepting spumaviruses, gamma- and epsilonretroviruses), several eukaryotic positive-strand RNA viruses, double-stranded RNA viruses of yeast, some plant RNA viruses and certain bacteriophage (see [@bib23], [@bib14], [@bib33], [@bib52], [@bib49], [@bib50], [@bib15], [@bib1], for reviews). In most of the systems studied to date, frameshifting is involved in the expression of replicases. In retroviruses, it allows the synthesis of the Gag-Pol and Gag-Pro-Pol polyproteins from which reverse transcriptase is derived and for most other viruses, frameshifting is required for expression of RNA-dependent RNA polymerases. Eukaryotic ribosomal frameshift signals consist of two essential mRNA elements: a "slippery" sequence, where the ribosome changes reading frame and a stimulatory RNA secondary structure, often an RNA pseudoknot, located a few nucleotides downstream ([@bib73]; [@bib17], [@bib131]). A spacer region between the slippery sequence and the stimulatory RNA is also present and a precise length of this spacer must be maintained for maximal frameshifting efficiency ([@bib17], [@bib19], [@bib81]). The slippery sequence is a heptanucleotide stretch that contains two homopolymeric triplets and conforms in the vast majority of cases to the motif XXXYYYZ (where X can be any nucleotide, Y is A or U and Z is not G). In eukaryotes, frameshifting is thought to occur by "tandem-slippage" of two ribosome-bound tRNAs, presumably peptidyl and aminoacyl tRNAs, which slip from the 0 (X_XXY_YYZ) to the −1 phase (XXX_YYY) ([@bib73]). The homopolymeric nature of the sequence seems to be required to allow the tRNAs to remain base-paired to the mRNA in at least two out of three anticodon positions following the slip. Recent work has revealed that the slippery sequence actually forms part of a slightly larger motif, as primary sequences immediately adjacent to the heptanucleotide stretch can influence the efficiency of frameshifting through various mechanisms ([@bib9], [@bib8]). In isolation, however, slippery sequences engender very low levels of frameshifting and a stimulatory RNA structure is needed to amplify the signal. There is considerable diversity in the structure of these RNAs and the precise mechanism by which they act is not resolved (reviewed in [@bib58], [@bib15]). In this article, frameshifting in the retrovirus human immunodeficiency virus type 1 (HIV-1) and the coronavirus responsible for severe acute respiratory syndrome (SARS) will be reviewed. The nature of the frameshift signals of HIV-1 and SARS--CoV will be discussed and the impact of this knowledge on models of frameshifting will be considered. The role of frameshifting in the replication cycle of the two pathogens and potential antiviral therapies targeting frameshifting will also be debated.

2. Frameshifting in HIV-1
=========================

HIV-1 is a lentivirus of the Retroviridae and the etiologic agent of acquired immune deficiency syndrome. A description of HIV replication and pathogenesis is far beyond the scope of this review; suffice to say that HIV-1 is responsible for great mortality and morbidity worldwide, has been the subject of intensive study, yet remains a huge global problem. There is an ongoing search for novel targets for antiviral intervention and a detailed molecular understanding of virus gene expression and replication, including frameshifting, may be beneficial in unearthing candidate targets. Although expression of the HIV-1 Gag-Pol polyprotein by ribosomal frameshifting was shown experimentally almost 20 years ago ([@bib74]), the structure of the signal and its role in virus replication have remained topics of debate. Without question, the site of frameshifting is the U_UUU_UUA stretch located within the *gag/pol* overlap some 200 nucleotides upstream of the *gag* termination codon. Protein sequencing has confirmed frameshifting at this site, although tandem-slippage of both peptidyl-tRNA^Phe^ and aminoacyl-tRNA^Leu^ accounts for only about 70% of the frameshift product, with the remaining 30% being derived from single slippage of peptidyl-tRNA^Phe^ on the U-rich stretch ([@bib74], [@bib143]). Mutational analysis has established that this region is essential both for frameshifting and virus replication ([@bib12]). Indeed, in a sequence comparison of one thousand HIV-1 isolates, the U_UUU_UUA sequence is entirely conserved ([@bib12]). In an early report, it was suggested that the U-rich stretch alone was sufficient for frameshifting in heterologous systems ([@bib139]) but it is now clear that a stimulatory RNA is necessary, although the precise structure of this element remains somewhat controversial ([Fig. 1](#fig1){ref-type="fig"} ). An examination of the sequences downstream of the HIV-1 slippery sequence and equivalent regions of the genomes of HIV-2 and simian immunodeficiency virus (SIV) suggested the involvement of a stem-loop structure ([@bib74]). Subsequently, mutational analysis, frameshift assays in transfected mammalian tissue culture cells and virus-infectivity assays have confirmed that the "original" stem-loop proposed by Jacks et al. is an essential component of the signal ([Fig. 1](#fig1){ref-type="fig"}A; [@bib104], [@bib81], [@bib122], [@bib66]) and that the extent of frameshifting is related to the predicted stability of this stem ([@bib11], [@bib66]). A number of more complex models have been proposed, however and these are shown in [Fig. 1](#fig1){ref-type="fig"}. Three of the models retain the original stem-loop as a key element, but propose additional interactions. In the model of [@bib86], the stem-loop is elaborated into an H-type pseudoknot by the interaction of three loop nucleotides with a region downstream to give a short stem 2 ([Fig. 1](#fig1){ref-type="fig"}B). In a further convolution, [@bib37] proposed an intramolecular triplex structure, where in addition to the pseudoknot, four adjacent and consecutive base triples form between bases in stem 1 and loop 2 ([Fig. 1](#fig1){ref-type="fig"}D). The model of [@bib44] also retained the original stem-loop but suggested an extension at the bottom of the stem by pairing of spacer nucleotides with a region downstream. The resulting two-stem helix is separated by a purine-rich bulge ([Fig. 1](#fig1){ref-type="fig"}E). Base-pairing of the spacer region was also proposed in the "short" pseudoknot model of [@bib43] ( [Fig. 1](#fig1){ref-type="fig"}C). The structure, although resembling certain other viral frameshift pseudoknots ([@bib15]) does not retain the original stem-loop element of Jacks and co-workers.Fig. 1Proposed stimulatory RNAs at the frameshift sites of HIV-1 and HIV-2. The HIV-1 signal is shown in panels A--E and that of HIV-2 in panel F. (A) Basic hairpin. The original stem-loop proposed by [@bib74] is shown with the slippery sequence UUUUUUA upstream (underlined). The *gag* reading frame is indicated as triplets. Sites of cleavage by the viral protease within the encoded polypeptides are indicated by arrows. (B) The pseudoknot model of [@bib86]. In this model, the two pseudoknot stems are connected by single-stranded loops of three (loop 1) and eight nucleotides (loop 2), respectively. (C) The small pseudoknot model of [@bib43]. Here, base-pairing of the spacer region immediately downstream of the slippery sequence allows an alternative pseudoknot to be drawn that does not include the original stem-loop of [@bib74]. (D) The triplex structure of [@bib37]. This model is based on the prediction of [@bib86] (panel B) but includes the formation of four triplexes between the 3′-end of loop 2 and the top of stem 1 (dotted lines). (E) The two-stem helix model of [@bib44] is the most favoured. Here, a short extension to the bottom of the original stem-loop is proposed, with an unpaired stretch (GGA) in the 3′-arm of the stem delineating the two-stem regions. (F) The HIV-2 (Rod) *gag*/*pro* frameshift signal can be folded to resemble the HIV-1 two-stem helix (panel E; see text).

Due to the related complementary pairing schemes of the various models, it has proven difficult to discriminate between them by standard structure probing and structure--function assays ([@bib75], [@bib37], [@bib44]) although on balance, the two-stem helix model proposed by the Brakier-Gingras Laboratory is most consistent with these data ([@bib44], [@bib6]; [Fig. 1](#fig1){ref-type="fig"}E). Further, the structure appears to be conserved in all subtypes of HIV group M, which constitutes \>99% of viral isolates responsible for the worldwide pandemic ([@bib6]). Recent NMR analysis of the HIV-1 frameshift signal also lends strong support to this model ([@bib123], [@bib124], [@bib55]).

The NMR data indicate that the HIV-1 stimulatory RNA possesses an apical stem in a continuous helix capped by a non-canonical U-G base-pair and an ACAA tetraloop. There is no evidence to support the formation of a pseudoknot or triplex. A less stable lower stem is present, separated from the upper stem by an asymmetric internal loop (GGA) which introduces a bend between the helices. Interestingly, the internal loop bases show continuous base-stacking, reminiscent of the internal loop of the HIV-1 SL1 stem-loop involved in genome packaging and reverse transcription ([@bib60], [@bib85]). SL1 is likely to be involved in binding of the viral Gag polyprotein during packaging; however, there is no evidence to suggest that the HIV frameshift stem-loop binds to Gag. It has been shown that both the lower stem and the internal loop of the HIV-1 frameshift region contribute to frameshift efficiency ([@bib44], [@bib6]), but the mechanism by which they exert their effects is not known. Indeed, this impinges on one of the central questions in the ribosomal frameshifting field and is considered in Section [4](#sec1){ref-type="sec"}. Analysis by *mfold* indicates that in most HIV-2 strains, the spacer can also be paired to give a similar two-stem structure containing a bulge (an example is shown in [Fig. 1](#fig1){ref-type="fig"}F), although the specific asymmetric internal loop of the HIV-1 signal is not apparent in the HIV-2 examples studied (ROD, BEN, D194, MCR35, 96FR12034). Remarkably, the stimulatory RNA of an HIV-1 group O (outlier) strain, MVP5180, is not a stem-loop but a pseudoknot ([@bib7]). Group O strains are thought to have originated from different monkey to human transmission events, which could explain the dissimilar frameshift signal, although it has been noted that another O strain, ANT70, cannot form the same pseudoknot as MVP5180, as sequence differences are present that would prevent the formation of stem 2 ([@bib7]).

The frameshift process is crucial to HIV replication as it allows expression of the Gag-Pol polyprotein and thus targeting of replicative enzymes to the particle core during assembly. It also sets a precise ratio of Gag:Gag-Pol polyproteins, with some 5--10% of translational events yielding Gag-Pol. Maintenance of this ratio appears to be essential. Expression of HIV Gag alone, although sufficient for assembly and release of virus-like particles, leads to non-infectious virions lacking indispensable viral enzymes (discussed in [@bib22]). Similarly, expression of the Gag-Pol polyprotein alone is detrimental, resulting in intracellular activation of the HIV-1 protease (PR) and inhibition of assembly and budding of virus-like particles ([@bib103], [@bib78], [@bib27]). Overexpression of Gag-Pol in T lymphocytes does lead to the secretion of virus-like particles, but these are non-infectious, not the least because they are devoid of genomic RNA ([@bib79]). Even subtle modulations of the Gag-Pol ratio can have profound effects on virus-infectivity. [@bib115] co-expressed Gag and Gag-Pol to generate an intracellular gradient of Gag:Gag-Pol ratios from 20:1 to 20:21 and found that genome RNA dimerisation was progressively inhibited as the concentration of Gag-Pol was increased and at approximately equimolar concentrations, HIV-1 infectivity was reduced about 1000-fold. Similarly, plasma virion isolates carrying stem-loops associated with greater than 60% reduction in frameshift efficiency were shown to have profound defects in replication ([@bib130]). Thus, even subtle modulations of the Gag:Gag-Pol ratio can substantially reduce virus fitness and this has implications for antiviral therapies (see below). More work is needed before a complete molecular explanation of the reduced viral fitness seen in such experiments is available. This is partly due to our incomplete understanding of the function of the proteins encoded in the frameshift region and also that the region is dual coding, which complicates mutational analysis. The organisation of the HIV-1 genome is shown in [Fig. 2](#fig2){ref-type="fig"} , focusing on the proteins encoded in the Gag and Gag-Pol polyproteins in the vicinity of the frameshift signal. Frameshifting in HIV-1, as in most retroviruses, allows expression of the viral PR required for polyprotein cleavage during maturation. In Gag, PR cleavage sites almost precisely flank the frameshift signal (see [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}) and yield, in addition to N-terminal proteins (MA, CA, p2, NC), the p1 and p6 (p6^Gag^) proteins. In Gag-Pol, the equivalent overlapping coding sequences are cleaved to produce the transframe octapeptide (TFP) and p6^\*^ (p6^Pol^). All of the proteins encoded by the frameshift region have important roles in the virus life cycle. Changing specific residues within spacer peptide p1 affects infectivity, processing and dimer stability, probably by influencing activity of p15-NC, the nucleocapsid-p1-p6^Gag^ precursor involved in genomic RNA binding ([@bib66]). p6^Gag^, which includes a late budding domain (PTAP), is essential for virus assembly and release ([@bib59]; reviewed in [@bib31], [@bib98]). The transframe region of Gag-Pol is critical for PR regulation. The TFP-p6^Pol^-PR intermediate has low dimer stability with TFP-p6^Pol^ functioning to inhibit PR until the appropriate point in maturation. Intramolecular cleavage at the p6^Pol^-PR site frees the N-terminus of PR, a critical step in the formation of a stable tertiary structure of PR and enzymatic activity ([@bib91], [@bib92]). TFP-p6^Pol^ can also inhibit PR directly, allowing further regulation ([@bib105]).Fig. 2Genomic organisation of HIV-1. Key features of the HIV-1 genome are shown. Non-coding regions include the terminal repeat regions (R) and the 5′- (U5) and 3′- (U3) untranslated regions. The coding regions (not to scale) comprise the *gag, pol* and *env* genes common to all retroviruses, plus the HIV-1 accessory genes *vif, vpr, tat, rev, vpu* and *nef*. The lower portion focuses on the proteins encoded at and adjacent to the *gag*/*pol* overlap. Black triangles indicate cleavage sites recognised by the viral protease (PR), which releases the capsid (CA), p2, nucleocapsid (NC), p1 and p6 (p6Gag) polypeptides from within the portion of the Gag polyprotein shown and the CA, p2, NC, transframe peptide (TFP), p6\* (p6Pol), PR and RT (reverse transcriptase) proteins from within the portion of the Gag-Pol polyprotein shown. The site of divergence between the polyproteins encoded by gag and gag-pol is indicated by an arrow (labelled fs \[frameshift\]).

The region of the genome that includes the frameshift region is likely to be of considerable importance in the development of resistance to antiviral drugs, particularly reverse transcriptase and PR inhibitors. There are several potential mechanisms that can be envisaged, including greater PR and reverse transcriptase production through frameshift regulation, enhanced packaging of viral enzymes via changes in p6^Gag^ and control of activation of the viral PR, via p6^Pol^ ([@bib108]). Regarding frameshifting, a novel Gag-Pol frameshift site has been documented in HIV-1 variants resistant to PR inhibitors ([@bib40]). In these isolates, the p1/p6^Gag^ cleavage site is changed from Phe-Leu to Phe-Phe, which at the nucleotide sequence level generates an additional homopolymeric and potentially slippery sequence (U_UUU_CUU to U_UUU_UUU) that could act to increase levels of Pol-encoded enzymes to counteract the PR deficit. This change is located within the lower stem of the Dulude structure (see above), yet the C to U transition is not predicted to destabilise the helix greatly (GU replaces GC pair). Despite lacking an obvious downstream stimulatory RNA, the novel sequence is functional in frameshifting (perhaps, because it contains seven consecutive U residues and may be more effective as a slippery sequence in the absence of a stimulatory RNA ([@bib73])) and supports Gag-Pol synthesis and PR activity in HIV molecular clones in which the authentic slippery sequence has been inactivated. The cleavage site mutation also generates a more effective cleavage site for both wild-type and PR-inhibitor-resistant proteases ([@bib39]). Thus, the reduced activity of drug-resistant proteases may be compensated for both by improved cleavage rates and increased levels of PR. It will be interesting to see whether other drug resistant isolates emerge that show stimulation of frameshifting independent of cleavage site changes, for example, by stabilisation of the stem-loop. There is no evidence that the virus itself can regulate frameshifting during replication however. In HIV-1 reporter constructs, for example, the level of frameshifting is not changed by co-infection with HIV-1 ([@bib21], [@bib114]). Similarly, the development of an infectious recombinant gammaretrovirus that expresses Gag-Pol by virtue of the HIV-1 frameshift signal rather than its natural readthrough signal argues against a specific role for HIV-encoded proteins in the frameshift process ([@bib20], [@bib56]).

3. Frameshifting in the SARS--CoV
=================================

The etiological agent of SARS is a novel coronavirus ([@bib42], [@bib51], [@bib83], [@bib84], [@bib107], [@bib112]) with the first documented cases being traced to Guangdong Province, China, in November 2002 ([@bib145], [@bib142]). In February 2003, the disease was introduced to Hong Kong ([@bib28], [@bib62]) and subsequently spread across 25 countries. Over 8000 cases and 774 deaths were attributed to this single outbreak (reviewed in [@bib111]). To date, the source of this virus remains unidentified. Epidemiological data suggest that it is zoonotic; some of the earliest community-infected patients had a history of either trading and slaughtering of wild animals or contact with urban rodents ([@bib145], [@bib142], [@bib121]).

Furthermore, viruses highly homologous (\>99% nucleotide identity) to SARS--CoV have been isolated from Himalayan palm civets (*Paguma larvata*) and a raccoon dog (*Nyctereutes procyonoides*) from live animal markets in Guangdong Province ([@bib61], [@bib121]). Characteristically, these isolates are phylogenetically related to those from the earliest independent human cases of SARS ([@bib29], [@bib121]). Ferrets (*Mustela furo*), domestic cats (*Felis domesticus*) and Himalayan palm civets have also been shown to shed virus after experimental infection with SARS--CoV ([@bib96], [@bib141]). Animal to human transmission of this virus has not yet been proven and the animal reservoir remains to be established.

Like all coronaviruses, the SARS--CoV genome is a single-stranded, non-segmented RNA of positive polarity. On the basis of phylogeny clustering, species of this genus are classified into three groups (1--3). Specifically, the SARS--CoV lineage has been proposed to cluster with group 2 ([@bib46], [@bib57], [@bib119]). Other human viruses monophyletically related are human coronaviruses OC43 ([@bib125], [@bib136], [@bib137]) and HKU1 ([@bib140]). The SARS--CoV genome is approximately 29.7 kb in length, with major genes arranged in a characteristic coronavirus pattern: 5′-replicase, spike, envelope, membrane, nucleocapsid-3′, flanked by untranslated regions (UTRs; see [Fig. 3](#fig3){ref-type="fig"} ). Additionally, nine ORFs in the intergenic regions between the spike and nucleocapsid genes are present and predicted to encode nine proteins of unknown function ([@bib95]).Fig. 3Genomic organisation of the SARS--CoV and the mechanism of translation of open reading frame (ORF) *1b*. Key features of the SARS--CoV genome are shown. Untranslated regions (UTRs) flank the genome at both ends. Major ORFs are present in the following order: 5′-replicase (*ORF1a*, *ORF1b*), spike (S), envelope (E), membrane (M) and nucleocapsid (N)-3′ (depicted in blue). Other predicted ORFs (in brown) encode proteins of unknown function. ORFs *1a* and *1b* are translated from the genomic RNA into polyproteins (pps) 1a and 1a/1b. The synthesis of the 1b portion of 1a/1b involves programmed −1 ribosomal frameshifting (−1 RFS). Arrows represent the corresponding polyprotein sites cleaved by the papain-like proteinase 2 (white) and the 3C-like proteinase (grey). The expanded view shows the nucleotide sequence of the overlapping region between ORFs 1a/1b (slippery sequence in red) and the corresponding amino acids of pps 1a and 1*a*/1*b*. Tandem-slippage of the peptidyl-tRNAs (codon UUA) and aminoacyl-tRNAs (codon AAC) on the slippery sequence switches the ribosome into the −1 reading frame (frame of ORF *1b*) and generates the amino acid sequences depicted.

The SARS--CoV replicase gene is organised into two partially overlapping ORFs (*1a* and *1b*), which encode the polyprotein 1a (nt 265--13,413 isolate Tor2) and the fused polyprotein 1a/1b (nt 265--13,398 and 13,398--21,485, isolate Tor2), synthesised by programmed −1 ribosomal frameshifting ([@bib132]). The site of frameshifting is a U_UUA_AAC stretch located 12 bases upstream of the *1a* stop codon. The overlap region of the SARS--CoV *1a*/*1b* ORF is thus much shorter than that of HIV-1. Another difference is the magnitude of the frameshift. Reporter plasmids encoding the SARS--CoV signal have indicated that the signal is highly efficient, measurements ranging between 14 and 27% in cell-free extracts and mammalian cells (cf. 5--10% for HIV-1) ([@bib132], [@bib38], [@bib4], [@bib110]). This proportion is consistent with the 15--40% described for other coronaviruses in the different phylogenetic groups ([@bib16], [@bib13], [@bib65], [@bib47]) and in related vertebrate and invertebrate nidoviruses ([@bib118], [@bib32], [@bib30]). This suggests that the stoichiometry of the ORF *1a*- and *1b*-encoded proteins has been evolutionarily conserved and might be critical for viral replication. Remarkably, ORF *1a* does not encode major structural protein and thus programmed −1 ribosomal frameshifting in the SARS--CoV (and other nidoviruses) has not evolved to regulate the ratio of structural to replication proteins as occurs with retroviral *gag*/*pol*.

Although high resolution structures of coronavirus *1a*/*1b* ribosomal frameshifting signals are not available, extensive mutational analysis, RNA structure probing and preliminary NMR studies indicate that they are composed of a U_UUA_AAC slippery sequence, followed by a single-stranded spacer region and an RNA pseudoknot (reviewed in [@bib14], [@bib15]; see also [@bib4], [@bib110]). In the signal of SARS--CoV, as in other coronaviruses, mutations in the codons corresponding to the ribosomal P-sites (UUA) and A-sites (AAC) of the slippery sequence greatly decrease −1 ribosomal frameshifting ([@bib132], [@bib4]) and changing the identity of bases immediately flanking the U_UUA_AAC stretch has little or no effect ([@bib4]). Mass spectroscopic analysis of a tagged frameshift product has indicated that the SARS--CoV frameshift occurs solely by tandem-slippage of the peptidyl-tRNA^Leu^ and aminoacyl-tRNA^Asn^ to the −1 reading frame codons ([@bib4]). Deletion analysis of the frameshift site indicates that the signal does not extend beyond 87 nucleotides downstream of the slippery sequence (Dos Ramos et al., unpublished work). Recent work has confirmed that this region contains an RNA pseudoknot structure with some unexpected features ([@bib38], [@bib4], [@bib110]; see [Fig. 4](#fig4){ref-type="fig"}A). The pseudoknot conforms to the H-type organisation in the possession of two base-paired stems (S1 and S2) and two single-stranded loops (L1 and L2), but extensive base-pairing seems to be present in loop 2 (which has alternatively been named SL1 or S3). Like all frameshift-promoting pseudoknots, disruption of base-pairing in either S1 or S2 reduces the efficiency of −1 ribosomal frameshifting substantially ([@bib4], [@bib110]). However, although most of loop 2 (SL1, S3) can be deleted without noticeable effect, maintenance of an appropriate conformation of the wild-type loop 2 seems to be required for optimal frameshift efficiency. Certain changes that affect the primary sequence (including bulge A residues) and the potential for the formation of SL1 have measurable effects on the frameshift process, probably by affecting global folding of the pseudoknot ([@bib4], [@bib110]). Pseudoknots containing an SL1 motif can be predicted for all group 2 coronaviruses ([@bib110]). In group 3 coronaviruses (e.g. infectious bronchitis virus), however, the region equivalent to SL1 is probably a single-stranded loop (a standard loop 2) ([@bib17], [@bib18], [@bib110]). The pseudoknots present at the *1a*/*1b* overlap of group 1 coronaviruses (e.g. human coronavirus 229E) appear to form a more "elaborated" pseudoknot that can be viewed as "kissing" stem-loops separated by a very long (∼150 nucleotides) loop 2 ([@bib64], [@bib47], [@bib4]). An alternative fold for pseudoknots of this group, with a much shorter loop 2 yet containing an SL1 region close to the junction with stem 2 can be drawn ([@bib110]), but with a relatively unstable stem 2, this conformation seems unlikely and is not supported by earlier mutational analysis ([@bib64]).Fig. 4Predicted RNA secondary structures present at the 1*a*/1*b* ribosomal frameshifting signals of the SARS Co-V and IBV. (A) SARS coronavirus. *Top:* predicted secondary structure. The pseudoknot is composed of two double-stranded stems (S1 and S2) connected by a single-stranded loop (L1) and a second loop (L2) which itself folds into a stem-loop of approximately 28 nucleotides (SL1). Numbers correspond to the nucleotide positions in isolate Tor2. *Bottom:* primary sequence comparisons. The SARS--CoV consensus shows the sequence of 125 isolates (identical in this region). Mutations have been seen in only two isolates (ZJ01 and GD69) and are of 1 or 2 nucleotides (depicted in red) within SL1 or S2. (B) Infectious bronchitis virus. The pseudoknot is composed of two double-stranded stems (S1 and S2) connected by two loops (L1 and L2). Nucleotides of L2 do not obviously base-pair to form a stable stem and were omitted from the graphic. Numbers correspond to the nucleotide position in the Beaudette strain. The "slippery" sequences are underlined.

The investigation of the SARS--CoV frameshift signal carried out in the laboratories of Atkins and Dinman ([@bib4], [@bib110]) has led to the discovery of a novel frameshift determinant within or adjacent to stem 2, although the exact motif remains to be defined. As drawn in [Fig. 4](#fig4){ref-type="fig"}, stem 2 contains an unpaired adenosine residue whose presence and identity has been proposed to be crucial to frameshifting; replacement by cytosine or deletion of this base reduces the frameshift efficiency to less than 1% ([@bib110]). Similarly, the work of [@bib4] has highlighted this region as important, but in their model, stem 2 is set at five base-pairs in length, with the "bulge" A and adjacent CA residues displaced into loop 2. This leaves two unpaired residues (GU) between stems 1 and 2, which these authors suggest are the key element. Unfortunately, the multiple base-pairing possibilities present in this region preclude definitive conclusions with the current data, but both groups have clearly identified an unexpected feature.

The function(s) of many coronavirus *1a*/*1b*-encoded proteins are not known and this has hindered our understanding of the role of frameshifting in this genus. Unlike retroviral Gag and Gag-Pol, the SARS--CoV 1a and 1a/1b polyproteins are cleaved intracellularly and the virus is not thought to package any 1a or 1b components into virions. 1a is processed into 11 products (non-structural proteins nsp1--11), mediated by the cysteine proteinases nsp3 (papain-like proteinase 2) and nsp5 (3C-like proteinase), which display substrate specificity for three (N-terminal) and seven (C-terminal) conserved sites of the polyprotein precursor, respectively ([Fig. 3](#fig3){ref-type="fig"}) ([@bib119], [@bib132], [@bib54], [@bib48], [@bib63], [@bib88], [@bib113]). Hitherto, the function of the other nsps remains undefined and only nsp9 has been partially characterised as a dimeric protein that binds both single-stranded RNA and single-stranded DNA ([@bib45], [@bib127]). The 1b polyprotein, expressed as a fusion with 1a is *trans-cleaved* by the 3C-like proteinase at four conserved sites ([Fig. 3](#fig3){ref-type="fig"}). This generates five nsps that include an RNA-dependent RNA polymerase (nsp12, which starts with the nine most N-terminal residues of nsp11) ([@bib26]); a superfamily 1 helicase with associated dNTPase, NTPase and RNA 5′-triphosphatase activities (nsp13) ([@bib132], [@bib129], [@bib70]); a putative 3′--5′ exonuclease (nsp14) ([@bib119]); an uridylate-specific endoribonuclease (nsp15) ([@bib10], [@bib71]); and a putative *S*-adenosylmethionine-dependent 2′-*O*-ribose cap-1 methyltransferase (nsp16) ([@bib119]; [@bib138]). At present, we can only speculate that the role of frameshifting is to set the relative levels of *1a*- and *1b*-encoded proteins. Indeed, for positive-stranded RNA viruses, the exact role of frameshifting is unknown. Presumably, the frameshift allows the required ratio of viral proteins to be produced, but it may also serve to downregulate levels of viral replicases, which may be toxic in high amounts.

4. Frameshift mechanisms {#sec1}
========================

Since −1 frameshifting was first described ([@bib72]), three inter-related models have circulated in the literature, the factor-binding, pausing and unwinding models. In the first model, the stimulatory RNA acts as a binding site for a protein(s) responsible for promoting or regulating the frameshift process ([@bib73], [@bib17]). However, despite fairly extensive study, no such proteins have been unearthed, although it cannot be ruled out that integral ribosomal component(s) may interact directly and specifically with the stimulatory RNAs. The second model proposes that ribosomal pausing occurs upon encounter of the stimulatory RNA and is a key element of the frameshift mechanism. In its simplest form, pausing increases the time at which ribosomes are held over the slippery sequence, giving increased opportunity for the tRNAs to realign in the −1 frame ([@bib73]). There is good evidence that pausing occurs at pseudoknot-dependent frameshift signals (although specific frameshift-inducing stem-loops have not been tested) and the site of pausing is consistent with placement of the ribosomal P- and A-sites over the slippery sequence ([@bib134], [@bib120], [@bib90], [@bib82]). One of the great virtues of the pausing model is its ability to accommodate the variety of stimulatory RNAs that are present at −1 frameshifting signals, including stem-loops. Regardless of the range of secondary and tertiary features presented to the ribosome, as long as pausing occurs, frameshifting results. The idea that pausing alone is sufficient to induce frameshifting is questionable, however. Simple provision of a roadblock to ribosomes in the form of stable RNA hairpins ([@bib18], [@bib120]), a tRNA ([@bib24]) or even different kinds of RNA pseudoknot ([@bib99], [@bib89]) is insufficient to bring about frameshifting and in addition, non-frameshifting pseudoknots and stem-loops exist that can still pause ribosomes ([@bib134], [@bib120], [@bib90], [@bib82]). Nevertheless, the pausing assays that are currently employed may be insufficiently sensitive to discriminate between a "kinetic pause" of perceivably short duration, yet essential for frameshifting and a "non-productive" pause resulting from a delay in unwinding the stimulatory RNA, but irrelevant to the process itself ([@bib11], [@bib82]). In the unwinding model, it is speculated that the stimulatory RNAs are particularly resistant to the action of a ribosome-associated RNA helicase responsible for unwinding mRNA structures ahead of the decoding centre ([@bib144], [@bib128]). RNA pseudoknots have been shown to possess unusual structural features which may be refractory to standard helix unwinding, for example triple helical regions formed between pseudoknot stem 1 and loop 2 ([@bib87], [@bib126], [@bib97]). Modelling studies predict that such triplexes are likely to be one of the first features of the pseudoknot to be encountered by the ribosome ([@bib58]), where it could function to stabilise stem 1 and increase the time taken to unwind the structure. As noted several years ago ([@bib41]) and re-iterated subsequently ([@bib97]), another potential barrier to unwinding is the unusual topology of the pseudoknot at the beginning of stem 1, where in addition to the two base-paired strands, loop 2 adds a third strand in close association ([Fig. 4](#fig4){ref-type="fig"}). Perhaps, the ribosome does not deal effectively with this kind of topological arrangement. Individual features of pseudoknots may also be important. The pseudoknot of the mouse mammary tumour virus (MMTV) *gag*/*pro* frameshift signal, for example, possesses a pronounced kink between stems 1 and 2, which may be important for frameshifting ([@bib116], [@bib24], [@bib25], [@bib77], [@bib76]). Similarly, the SARS--CoV pseudoknot seems to possess a frameshift determinant within or adjacent to stem 2 that plays an important role.

[@bib109] have recently proposed an elegant model for frameshifting, the 9 Å model, which offers a possible molecular explanation for tRNA movement. Here, ribosomes are paused by their initial failure to unwind the stimulatory RNA whilst in the act of accommodating the A-site tRNA from the A--T state into the A-site proper (A--A state) of the ribosome. During the accommodation process, the anticodon of the A-site tRNA is thought to move about 9 Å ([@bib101]). As the mRNA is essentially held in place by the stimulatory RNA blocking the mRNA channel, the movement of the anticodon, as part of an mRNA codon: anticodon complex, puts strain on the mRNA that may be relieved by −1 slippage of the tRNA. The 9 Å model is consistent with former models in that a failure to unwind the stimulatory RNA is crucial in allowing the A-site anticodon movement to generate tension and pausing of the ribosome would extend the window in which tRNA movement can take place. The resistance to unwinding could also be facilitated by binding of the pseudoknot to proteins in and around the mRNA channel.

As is clear from the above, frameshift models have been tailored mostly towards pseudoknot-containing sites and rely on pseudoknot-specific features. How then do we explain the capacity of stem-loops to induce frameshifting? One possibility is that the stem-loops themselves possess hitherto uncharacterised, novel structural features that can interfere with unwinding or promote the kind of ribosomal pause that leads to frameshifting. The high-resolution structure of the HIV-1 frameshift stem-loop discussed above is an important step forward in this regard. The presence of a kink between the upper and lower base-paired stems of the HIV-1 stimulatory RNA is reminiscent of the inter-stem kink present in the MMTV pseudoknot and may represent an important structural feature. The HIV-1 hairpin is capped by a tetraloop motif which may also be relevant to frameshifting. Of course, it may be that our models of frameshifting are incomplete. Mutational analysis of such sites has already provided hints that the traditional combination of slippery sequence and hairpin may not be the sole defining feature of the signal and other elements may contribute. [@bib80] measured the frameshift efficiencies evoked in vitro by a series of HIV-1 *gag*/*pol*-human T-cell lymphotropic virus type 2 (HTLV-2) *gag*/*pro* chimeras. They defined four elements, namely the slippery sequence, spacer, stem-loop and a region *upstream* of the slippery sequence and combined these in various ways to create a range of hybrid sites. It was found that the regions flanking the slippery sequence and stem-loop could influence frameshifting quite dramatically, possibly by modulating stem-loop unfolding kinetics. Thus, frameshifting at stem-loop structures, like at pseudoknots, is likely to be governed by the rate at which the structure is unfolded. It has recently been discovered that simply annealing an oligonucleotide downstream of a slippery sequence can under certain circumstances promote efficient frameshifting, at least in in vitro translation systems ([@bib67], [@bib102]). In this situation, the ribosome encounters a double-stranded region conformationally distinct from a stem-loop, yet similarly, the rate of unwinding of the structure is likely to be the key determinant of frameshifting efficiency.

5. Frameshifting as a target for antiviral intervention
=======================================================

From studies of HIV and other retroviruses, it is clear that modulation of frameshift efficiency can have a dramatic effect on virus viability and the same is likely to be true for positive-strand RNA viruses, since it would alter the levels of non-structural proteins within infected cells. Various antibiotics that target ribosomes have been found to influence frameshifting efficiency at the yeast double-stranded RNA virus (L--A) signal ([@bib34]) and this has led to the working hypothesis that they could be used as antiviral drugs ([@bib35], [@bib36], [@bib69]). However, it remains to be seen whether such compounds (e.g. anisomycin, sparsomycin, cycloheximide) have activity against a broad-spectrum of frameshifting signals. High-throughput screening has also been employed in the search for candidate anti-frameshift drugs active against the HIV-1 stem-loop signal ([@bib68]). One such compound, RG501 (1,4-bis-\[*N*-{3-*N*,*N*-dimethylpropyl} amidino\] benzene tetrahydrochloride) was found to stimulate frameshifting at the HIV-1 signal about two-fold and inhibited HIV-1 replication in tissue culture. However, this inhibition began at levels of RG501 that did not noticeably affect frameshifting, so the specificity of the effect is questionable and the issue may be complicated by cytotoxicity. The drug was nevertheless clearly able to stimulate frameshifting at the stem-loop-containing signals of HIV-2, SIV and HTLV I *gag/pro,* but not HTLV-1 *pro/pol,* which is thought to contain a pseudoknot ([@bib131]). It has been speculated ([@bib68]) that RG501 acts by binding to the loop region of hairpins (perhaps by intercalation), stabilising the structure and promoting frameshifting by increasing ribosomal pausing. Targeting of oligonucleotides to frameshift signals may also permit antiviral intervention, for example, through inhibition of frameshifting by interfering with formation of the stimulatory RNA or by stimulation of frameshifting. It is known that the binding of 2′-*O*-methyl oligoribonucleotides to a region just 3′-wards of the HIV-1 stimulatory RNA leads to an enhancement of frameshift efficiency in vitro, perhaps by (effectively) increasing the length of the stem of the HIV-1 stimulatory RNA ([@bib135]). Some of the ground rules for oligonucleotide targeting of the HIV-1 frameshift stem-loop have already been worked out ([@bib2], [@bib3], [@bib133]). So far, however, only one group has demonstrated reduced virus replication upon oligonucleotide-targeting of a frameshift region ([@bib100]). In this study, a peptide-conjugated phosphorodiamidate morpholino antisense oligomer targeting the pseudoknot stems of the SARS--CoV frameshift signal showed demonstrable antiviral activity. Recent work in our laboratory has also focused on targeting the SARS--CoV frameshifting signal with antisense RNA and chimeric RNA/DNA oligonucleotides (Dos Ramos et al., unpublished work). Specific inhibition of frameshifting independent of mRNA cleavage has been demonstrated in an in vitro translation system using oligonucleotides complementary to different regions of the pseudoknot. Highly active oligonucleotides are currently being tested in vivo*.* Importantly, the structures of some domains (e.g. S1, SL1) are highly conserved ([Fig. 4](#fig4){ref-type="fig"}) raising hopes that such targeting could be broad-spectrum and less susceptible to the generation of escape mutants.

Another issue concerns the occurrence of frameshifting in cellular genes. Recently, a programmed −1 frameshifting signal has been described in the mouse gene *Edr* ([@bib117]). The *Edr* signal resembles retroviral examples closely, with a characteristic slippery sequence---spacer-pseudoknot organisation ([@bib94]) and the signal is conserved in the human orthologue *PEG10* ([@bib93]). Given the possibility that other retrovirus-like motifs have been subsumed into mammalian genes and retained a role for frameshifting, antiviral agents that target this process may have previously unanticipated consequences on cellular metabolism in uninfected cells.

6. Conclusions
==============

It is now established that the stimulatory RNAs present at the frameshift signals of HIV-1 and SARS--CoV are examples of stem-loop and pseudoknot stimulators, respectively. However, there remain a number of unanswered questions. Regarding the HIV-1 signal, one of the key uncertainties is whether the stem-loop pauses ribosomes to the same extent as an RNA pseudoknot and at the same place on the mRNA. Pausing assays would confirm that frameshift-stimulating stem-loops can indeed stall ribosomes and may help in judging whether current pausing assays are of much value. Further investigation of the contribution of specific subdomains of the HIV-1 stimulator to the frameshift process is also appropriate, including the role of the GGA bulge (the kink), the base-paired spacer, the potential role of the tetraloop and the occurrence of these motifs in other lentiviruses. The SARS--CoV signal also requires more analysis, especially the role of SL1 and the determinant at the S1--S2 junction. An atomic structure of a pseudoknot of this class would be of immense value in identifying common motifs amongst frameshift-promoting pseudoknots; the preliminary NMR studies of [@bib110] offer some hope that this can be achieved. The recent development of methods to prepare infectious molecular clones of coronaviruses offers for the first time the opportunity to investigate the role of frameshifting in the replication of the SARS--CoV (reviewed in [@bib5]). This will be of broad relevance to frameshifting in positive-strand RNA viruses. The huge public health consequences of the HIV-1 pandemic and concerns over future SARS--CoV outbreaks demands that all avenues be explored in the quest to counteract these agents. In principle, the replication of any virus that uses a frameshift process could be disrupted by modulation of frameshift efficiencies, but a better understanding of the occurrence and the molecular basis of frameshifting will be required before it can be considered as a genuine target.
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